Furthermore, fraxin downregulated IL-6 and TNF-α expression and lowered the gene and protein levels of FAT/CD36, controlling key targets in signaling pathways related to lipid metabolism and atherosclerosis. This evidence concerns the gene CD36 and atherosclerosis.